Johnson & Johnson $99.96

down -0.26


24/4/2014 06:40 PM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has underperformed the S&P 500 by 1%

Partner Headlines

  1. 7 Dividend Stocks Headed in the Right Direction

    GuruFocus
  2. My First $10,000 Investment

    GuruFocus
  3. Expeditors Played China Trade Boom To A 38,523% Gain

    IBD
  4. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  5. Two High-Yielding Opportunities Still Available At Cheap Prices

    GuruFocus
  6. The Market is Going to Crash. A Dividend Investors Guide to 3 Stocks You ...

    GuruFocus
  7. The Market is Going to Crash - A Dividend Investor's Guide to 3 Stocks ...

    GuruFocus
  8. Why I Only Buy Companies That Consistently Pay And Raise Dividends

    GuruFocus
  9. #PreMarket Primer: Thursday, April 17: Violence In Ukraine Could Deter ...

    Benzinga
  10. Investor Steven Romick's Top 5 Increases of First Quarter

    GuruFocus
  11. Who Owns the Top Dividend Stocks?

    GuruFocus
  12. UPDATE: Bank of America Reiterates on Johnson & Johnson Following Strong ...

    Benzinga
  13. UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock

    Benzinga
  14. #PreMarket Primer: Wednesday, April 16: Chinese GDP Slows, But Surpasses ...

    Benzinga
  15. J&J Gains On Modest Q1 Beat

    IBD
  16. If Airbnb’s Worth $10B, HomeAway’s A Bargain

    YCharts
  17. Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as ...

    Benzinga
  18. Mid-Day Market Update: US Stocks Turn Red; Pep Boys Shares Drop After Q4 ...

    Benzinga
  19. The Market Is Not Acting Right

    Benzinga
  20. J&J Earnings Beat Estimates As Pharma Sales Shine

    IBD
  21. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  22. Stock Futures Firmly Higher; Zebra, Coca-Cola, J&J Surge

    IBD
  23. UPDATE: Johnson & Johnson Posts Upbeat Q1 Earnings, Lifts FY14 Outlook

    Benzinga
  24. J&J Tops Street Views Amid Strong Drug Sales

    FoxBusiness
  25. Stock Futures Tick Up Amid Upbeat Earnings

    FoxBusiness
  26. Strong Corporate Earnings Lift Wall Street

    FoxBusiness
  27. ETF Outlook for Tuesday, April 15, 2014 (EWH, FCG, PSP, HDV)

    Benzinga
  28. #PreMarket Primer: Tuesday, April 15: Hopes For Diplomacy In Ukraine Help ...

    Benzinga
  29. Earnings Scheduled For April 15, 2014

    Benzinga
  30. Stocks To Watch For April 15, 2014

    Benzinga
  31. #PreMarket Primer: Monday, April 14: Military Action In Ukraine Looking ...

    Benzinga
  32. 4 Top Stocks in the Medical Device Sector

    GuruFocus
  33. Benzinga Weekly Preview: Short, But Action Packed Week Ahead

    Benzinga
  34. Week Ahead: Loads of Bank Earnings

    FoxBusiness
  35. Top 40 Upcoming Earnings Releases

    Benzinga
  36. ADP's

    IBD
  37. #PreMarket Primer: Thursday, April 10: Job Creation Will Be China's Main ...

    Benzinga
  38. #PreMarket Primer: Wednesday, April 9: John Kerry Accuses Russia Of Stirring ...

    Benzinga
  39. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  40. Is The Market Still Playing Defense?

    Benzinga
  41. Nasdaq Slumps 2.6%; Growth Stocks Bear Brunt Of Selling

    IBD
  42. Growth Names Pressured; Nasdaq Gives Up 50-Day Line

    IBD
  43. Is Dividend Machine JNJ a Buy?

    GuruFocus
  44. J&J, Carlyle in $4 bil unit sale

    IBD
  45. Benzinga's M&A Chatter for Monday March 31, 2014

    Benzinga
  46. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy

    Benzinga
  47. Weekly 52-Week Highs Highlight: MAR, JNJ, HAL, BHI

    GuruFocus
  48. Stocks Rising In Soft Trade; GE, Intel, J&J Advancing

    IBD
  49. Stocks Hitting 52-Week Highs

    Benzinga
  50. J&J Agrees to Sell Ortho Arm to Carlyle for $4B

    FoxBusiness
Trading Center